Keyphrases
Adverse Effects
100%
Airway Response
16%
Asthma
100%
Asthma Symptoms
16%
Buccal Absorption
16%
Clinical Benefit
16%
Crossover Design
16%
Drug Administration
16%
First-pass Metabolism
16%
Forced Expiratory Volume in 1 Second (FEV1)
33%
Heart Rate
16%
Initial Delay
16%
Metered Dose Inhaler
66%
Microgram
66%
No Adverse Effect
16%
No Significant Difference
16%
Oral Route
16%
Pharmacodynamics
16%
Pharmacokinetic Effects
100%
Pharmacokinetic Parameters
16%
Pharmacokinetic Profile
16%
Placebo
33%
Plasma Potassium
16%
Salbutamol
100%
Sublingual
100%
Sublingual Administration
16%
Sublingual Route
16%
Sublingual Tablets
16%
Systemic Absorption
33%
Tremor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Drug Administration
16%
Finger Tremor
16%
First Pass Effect
16%
Isotopes of Potassium
16%
Metered-Dose Inhaler
66%
Pharmacodynamic Parameter
16%
Pharmacokinetic Parameter
16%
Pharmacokinetics
100%
Placebo
33%
Salbutamol
100%
Sublingual Administration
16%
Sublingual Route
16%
Tablet
83%